In a case with wide-ranging implications for how broad patent protections can be, Sanofi and Regeneron are calling on the Supreme Court to deny Amgen’s attempt to overturn an appeals court’s rejection of Amgen’s patent for its blockbuster cholesterol treatment Repatha (evolocumab). Read More

In this special report, Drug Industry Daily examines how the drug supply chain has evolved during the pandemic. Part 2 focuses on efforts to shore up the supply chain, including the promotion of domestic manufacturing. Read More

Bayer and EMD Serono have joined the list of drugmakers limiting the discounts they provide to participating 340B hospitals. Read More

In this special report, Drug Industry Daily examines how the drug supply chain has evolved during the pandemic. Part 1 focuses on the special challenges to manufacturers of generics. Read More

Bristol Myers Squibb (BMS) has filed a complaint in federal court alleging AstraZeneca’s cancer therapy Imjudo (tremelimumab) infringes on its blockbuster immunotherapy drug Yervoy (ipilimumab). Read More